Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Machine Learning Identification of Cell-Type-Specific Molecular Signatures Distinguishing COVID-19 from Other Lower Respiratory Tract Diseases.

Life (Basel, Switzerland)·2026

Same author

Machine Learning-Based Identification of Candidate Serum miRNA Features for Pan-Cancer and Cancer Type Classification.

Life (Basel, Switzerland)·2026

Same author

Association between gut microbiota and imaging biomarkers in arteriosclerotic cerebral small vessel disease with idiopathic normal pressure hydrocephalus.

Frontiers in neuroscience·2026

Same author

Network Analysis in Microbiome Research: Methods, Tools, and Applications.

Methods in molecular biology (Clifton, N.J.)·2026

Same author

The Role of EBV Infection and Epigenetic Factors in Radioresistance of Colorectal Cancer.

Methods in molecular biology (Clifton, N.J.)·2026

Same author

RNA Large Language Models in Virology.

Methods in molecular biology (Clifton, N.J.)·2026

Same journal

Correction: Yalçın et al. Impact of SGLT2 Inhibitors on Cardiovascular Risk Scores, Metabolic Parameters, and Laboratory Profiles in Type 2 Diabetes. <i>Life</i> 2025, <i>15</i>, 722.

Life (Basel, Switzerland)·2026

Same journal

Correction: Schubert et al. Minimally Invasive Ablation Strategies for Renal Cell Carcinoma Patients Ineligible for Surgery. <i>Life</i> 2026, <i>16</i>, 73.

Life (Basel, Switzerland)·2026

Same journal

Blood Group Antigen Combinations and COVID-19: Complexity, Associations and Possible Clinical Relevance.

Life (Basel, Switzerland)·2026

Same journal

Beyond HPV in Eastern Europe: Genotype Distribution, Molecular Biomarkers, Vaginal Microbiome, and Implications for Cervical Cancer Prevention.

Life (Basel, Switzerland)·2026

Same journal

Therapeutic Effects of <i>Scutellaria baicalensis</i> Georgi Extract and Baicalein on Olfactory Dysfunction and Neurobehavioral Alterations in a Methimazole-Induced Injury Model.

Life (Basel, Switzerland)·2026

Same journal

The Effects of Unstable Strength Training on Lower Limb Stability in Adolescent Volleyball Players in China.

Life (Basel, Switzerland)·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Aug 16, 2025

mirMachine: A One-Stop Shop for Plant miRNA Annotation

mirMachine: A One-Stop Shop for Plant miRNA Annotation

Published on: May 1, 2021

Identifying MicroRNA Markers That Predict COVID-19 Severity Using Machine Learning Methods.

Jingxin Ren¹, Wei Guo², Kaiyan Feng³

¹School of Life Sciences, Shanghai University, Shanghai 200444, China.

Life (Basel, Switzerland)

|December 23, 2022

Summary

This summary is machine-generated.

This study identifies microRNAs (miRNAs) as potential biomarkers for predicting COVID-19 severity. A computational framework successfully distinguished between different disease severities using blood miRNA expression profiles.

Keywords:

COVID-19 MicroRNA SARS-CoV-2 biomarker feature analysis rules

More Related Videos

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

Lung microRNA Profiling Across the Estrous Cycle in Ozone-exposed Mice

Lung microRNA Profiling Across the Estrous Cycle in Ozone-exposed Mice

Published on: January 7, 2019

Related Experiment Videos

Last Updated: Aug 16, 2025

mirMachine: A One-Stop Shop for Plant miRNA Annotation

mirMachine: A One-Stop Shop for Plant miRNA Annotation

Published on: May 1, 2021

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

Lung microRNA Profiling Across the Estrous Cycle in Ozone-exposed Mice

Lung microRNA Profiling Across the Estrous Cycle in Ozone-exposed Mice

Published on: January 7, 2019

Area of Science:

Biochemistry
Genomics
Computational Biology

Background:

SARS-CoV-2 infection presents a spectrum of illness, from asymptomatic to fatal respiratory impairment.
MicroRNAs (miRNAs) are implicated in antiviral responses and show potential as biomarkers for COVID-19 clinical severity.
Distinguishing COVID-19 severity is crucial for patient management and understanding disease mechanisms.

Purpose of the Study:

To identify and validate microRNA (miRNA) biomarkers for differentiating COVID-19 clinical severity.
To develop and apply an efficient computational framework for analyzing miRNA expression profiles in diverse patient cohorts.
To explore the potential of identified miRNAs as diagnostic markers and therapeutic targets for COVID-19.

Main Methods:

Combined and analyzed blood miRNA expression profiles from 375 patients across six categories (mild/moderate/severe COVID-19, mild/severe non-COVID-19, healthy controls).
Designed a computational framework integrating four feature selection methods (LASSO, LightGBM, MCFS, mRMR) and four classification algorithms (DT, KNN, RF, SVM).
Constructed a high-precision Random Forest (RF) model achieving a 0.780 weighted F1 score for classifying disease severity.

Main Results:

Identified specific miRNAs, including miR-24-3p and miR-148a-3p, differentially expressed in patients with varying COVID-19 severity and complications.
The developed computational framework demonstrated high accuracy in screening clinical miRNA markers.
Extracted classification rules using a Decision Tree (DT) model to quantitatively represent miRNA's role in differentiating COVID-19 severity.

Conclusions:

The study successfully identified potential miRNA biomarkers for predicting COVID-19 severity.
The computational framework is effective and accurate for screening clinical miRNA markers.
These findings could enhance clinical diagnosis, elucidate SARS-CoV-2 infection mechanisms, and reveal new therapeutic targets.